References
- SalvaraniCHunderGGMusculoskeletal manifestations in a population-based cohort of patients with giant cell arteritisArthritis Rheum1999421259126610366120
- YanaiHFurutaniNItoKYoshidaHTadaNScintigraphic findings and serum matrix metalloproteinase 3 and vascular endothelial growth factor levels in patients with polymyalgia rheumaticaThe Open General and Internal Medicine Journal200935357
- ChuangTYHunderGGIlstrupDMKurlandLTPolymyalgia rheumatica: a 10-year epidemiologic and clinical studyAnn Intern Med1982976726806982645
- RibbensCMartin y PorrasMFranchimontNIncreased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatmentAnn Rheum Dis20026116116611796404
- MeliconiRPulsatelliLDolzaniPVascular endothelial growth factor production in polymyalgia rheumaticaArthritis Rheum2000432472248011083270
- SmeethLCookCHallAJIncidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–200Ann Rheum Dis2006651093109816414971
- DasguptaBHutchingsAMattesonELPolymyalgia rheumatica: the mess we are now in and what we need to do about itArthritis Rheum20065551852016874793
- DasguptaBSalvaraniCSchirmerMDeveloping classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider surveyJ Rheumatol20083527027718050370
- PeterselDLSigalLHReactive arthritisInfect Dis Clin North Am20051986388316297737
- AnnounNGuernePATreating difficult crystal pyrophosphate dihydrate deposition diseaseCurr Rheumatol Rep20081022823418638432
- SongJSLeeYHKimSSParkWA case of calcium pyrophosphate dihydrate crystal deposition disease presenting as an acute polyarthritisJ Korean Med Sci20021742342512068153
- Pego-ReigosaJMRodriguez-RodriguezMHurtado-HernandezZCalcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptomsArthritis Rheum20055393193816342107
- McCartyDJO’DuffyJDPearsonLHunterJBRemitting seronegative symmetrical synovitis with pitting edema. RS3PE syndromeJAMA1985254276327674057484
- OliveAdel BlancoJPonsMVaqueroMTenaXThe clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. The Catalan Group for the Study of RS3PEJ Rheumatol1997243333369034993
- PulsatelliLDolzaniPSilvestriTSynovial expression of vasoactive intestinal peptide in polymyalgia rheumaticaClin Exp Rheumatol20062456256617181926
- ArimaKOriguchiTTamaiMRS3PE syndrome presenting as vascular endothelial growth factor associated disorderAnn Rheum Dis2005641653165516227418
- TriplettLMPfisterAKThe clinical entity of remitting seronegative synovitis with pitting edema (RS3PE syndrome)W V Med J20019730230411828677